Contractor profile
Abbott Rapid DX North America LLC
FY2023 · complete year · data as of 2026-07-03
No FY2026 activity recorded for this recipient. Showing FY2023, its most recent year with data.
prime recipient of federal awards · UEI P782RNU1NNK3 Source
$260.4M
Obligated
FY2023
6
Funding agencies
99%
From Health and Hum…
7
States
100%
In Florida
6
Industries
In FY2023, Abbott Rapid DX North America LLC received $260.4M in federal awards from 6 agencies, 99% of it from the Department of Health and Human Services, with 100% of the work performed in Florida. Across FY2020 to FY2023 its recorded total is $4.4B. Computed
Where this money comes from
SourceFUNDING AGENCIES
ABBOTT RAPID DX NORTH AM
HHS
$0.3B
5 other agencies
$0B
Abbott Rapid DX North America LLC
$0.3B
FY2023 obligated
Where the work lands
SourceKey takeaways
Computed- Abbott Rapid DX North America LLC received $260.4M in federal obligations in FY2023, down 87% from $2B in FY2022.
- The Department of Health and Human Services accounted for 98% of it.
- Its largest recorded industry was In-Vitro Diagnostic Substance Manufacturing, at $259M.
- Florida was its largest place of performance, with 99% of the work.
Obligations by year
Computed$280.7M
FY20
$1.9B
FY21
$2B
FY22
$260.4M
FY23
▼ 7%
since FY20
Awards
SourceLargest active awards by total value
Awards whose period of performance overlaps FY2023, by the amount obligated on each so far.
| Award | ID | Agency | Obligated | Start | End | Place |
|---|---|---|---|---|---|---|
| Contract SPE2DS22F0019 | SPE2DS22F0019 | Department of Defense | $265.7M | 2021-10-20 | 2023-06-26 | Florida |
| Contract SPE2DS21F0129 | SPE2DS21F0129 | Department of Defense | $264M | 2021-09-24 | 2023-03-16 | Florida |
| Over the Counter (OTC) COVID-19 Tests | 75A50223C00001 | Department of Health and Human Services | $257.1M | 2022-12-07 | 2023-03-30 | Florida |
| Contract SPE2DS22F0021 | SPE2DS22F0021 | Department of Defense | $85.3M | 2021-10-20 | 2024-02-13 | Florida |
Largest FY2023 awards
Awards that started in FY2023, by the amount obligated on each so far.
| Award | ID | Agency | Obligated | Start | End | Place |
|---|---|---|---|---|---|---|
| Over the Counter (OTC) COVID-19 Tests | 75A50223C00001 | Department of Health and Human Services | $257.1M | 2022-12-07 | 2023-03-30 | Florida |
What it does (NAICS / PSC)
Corporate family
Single registration: no combined family.
Related
- Top contractors of the Department of Health and Human Services Its largest funding agency, ranked by recipient
- Department of Health and Human Services Its largest funding agency
- In-Vitro Diagnostic Substance Manufacturing Its largest recorded category
- Florida Where most of its work is performed
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers Another of its largest categories
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.